Effect of mutations in XPD(ERCC2) on pregnancy and prenatal development in mothers of patients with trichothiodystrophy or xeroderma pigmentosum

[1]  X. Ambroggio,et al.  Phenotype-specific adverse effects of XPD mutations on human prenatal development implicate impairment of TFIIH-mediated functions in placenta , 2012, European Journal of Human Genetics.

[2]  K. Kraemer,et al.  SHINING A LIGHT ON XERODERMA PIGMENTOSUM , 2012, The Journal of investigative dermatology.

[3]  Sikandar G. Khan,et al.  High‐risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies , 2011, Prenatal diagnosis.

[4]  J. Egly,et al.  A history of TFIIH: two decades of molecular biology on a pivotal transcription/repair factor. , 2011, DNA repair.

[5]  Sikandar G. Khan,et al.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair , 2010, Journal of Medical Genetics.

[6]  Sikandar G. Khan,et al.  Brittle hair, developmental delay, neurologic abnormalities, and photosensitivity in a 4-year-old girl. , 2010, Journal of the American Academy of Dermatology.

[7]  J. Troendle,et al.  Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development , 2010, Clinical genetics.

[8]  J. Tolmie,et al.  Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome , 2010, Human mutation.

[9]  J. Egly,et al.  Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients , 2009, The Journal of experimental medicine.

[10]  Sikandar G. Khan,et al.  Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer‐prone xeroderma pigmentosum vs. non‐cancer‐prone trichothiodystrophy , 2008, Human mutation.

[11]  J. Tolmie,et al.  Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation , 2008, Journal of Medical Genetics.

[12]  K. Kraemer,et al.  Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations , 2008, Journal of Medical Genetics.

[13]  C. Kisker,et al.  Crystal Structure of the FeS Cluster–Containing Nucleotide Excision Repair Helicase XPD , 2008, PLoS biology.

[14]  Lester G. Carter,et al.  Structure of the DNA Repair Helicase XPD , 2008, Cell.

[15]  J. Tainer,et al.  Supplemental Experimental Procedures Cloning and Recombinant Protein Production , 2022 .

[16]  R. Schiffmann,et al.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: A complex genotype–phenotype relationship , 2007, Neuroscience.

[17]  C. Arlett,et al.  Xeroderma pigmentosum (complementation group D) mutation is present in patients affected by trichothiodystrophy with photosensitivity , 1986, Human Genetics.

[18]  B. Van Houten,et al.  Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. , 2003, Molecular cell.

[19]  J. Graham,et al.  Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. , 2001, American journal of human genetics.

[20]  A. Lehmann,et al.  The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. , 2001, Genes & development.

[21]  A. Lehmann,et al.  Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. , 1998, American journal of human genetics.

[22]  A. Lehmann,et al.  Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Watchko,et al.  Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. , 1994, The Journal of pediatrics.

[24]  M. Nance,et al.  Cockayne syndrome: review of 140 cases. , 1992, American journal of medical genetics.

[25]  K. Kraemer,et al.  Xeroderma Pigmentosum: Cutaneous, Ocular, and Neurologic Abnormalities in 830 Published Cases , 1987 .

[26]  R. Pollitt,et al.  Sibs with mental and physical retardation and trichorrhexis nodosa with abnormal amino acid composition of the hair. , 1968, Archives of disease in childhood.